SAB Biotherapeutics Inc
(NAS:SABS)
$
3.77
+0.085 (+2.3%)
Market Cap: 343.02 Mil
Enterprise Value: 245.52 Mil
PE Ratio: 0
PB Ratio: 1.47
GF Score: 26/100 SAB Biotherapeutics Inc (SABS) Transcripts
- 1